<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02117388</url>
  </required_header>
  <id_info>
    <org_study_id>27264</org_study_id>
    <secondary_id>1R01MH101468-01</secondary_id>
    <nct_id>NCT02117388</nct_id>
  </id_info>
  <brief_title>Treatments for Insomnia: Mediators, Moderators and Quality of Life</brief_title>
  <official_title>Treatments for Insomnia: Mediators, Moderators and Quality of Life</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Palo Alto Veterans Institute for Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the relative efficacy and effectiveness of specific
      components of cognitive behavioral therapies for insomnia: sleep restriction (SR) and
      cognitive therapy (CT) in comparison to combined SR and CT (SR+CT).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      As many as one in three older adults may experience insomnia. Older adults are the most
      frequent users of hypnotic medications. Although safer, use of even the latest &quot;sleeping
      pills&quot; can lead to cognitive impairment and risk of falls. Thus, it is not surprising that
      non-pharmacological treatments for insomnia have been pursued as alternatives to medications,
      with some suggesting they should be the &quot;first line of therapy&quot;. We propose a randomized
      clinical trial to evaluate the relative efficacy and effectiveness of specific components of
      cognitive behavioral therapies for insomnia (CBT-I): sleep restriction (SR) and cognitive
      therapy (CT) in comparison to combined SR and CT (SR+CT). We hypothesize that because the
      proposed mechanisms of action of CT versus SR substantially differ, their combination may
      have additive effects. Even though the mechanisms of action of SR and CT may differ, no data
      exists to document that the addition of one to the other provides more overall clinical
      benefit than either intervention alone. Finally, to better understand &quot;how&quot; and &quot;in whom&quot; SR
      and CT work, we plan to formally evaluate selected mediators and moderators of the clinical
      effect including physiological measures of anxiety and arousal. Three treatments (SR, CT, and
      SR+CT) will be compared in a randomized clinical trial with a parallel groups design.
      Efficacy and effectiveness data will be collected prior to the beginning of treatment, after
      6 weeks of treatment, and at the end of a 6-month follow-up. These efforts follow the
      National Institute of Mental Health Strategic Plan Strategy 3.1 to develop innovative
      interventions and designs for intervention studies, in this case, to promote a new
      intervention trial that focuses on the mediators and moderators of treatment response.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insomnia Severity Index</measure>
    <time_frame>Screening, End of 6-week treatment, 6-month follow-up</time_frame>
    <description>Subject's subjective evaluation of their sleep.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognitive Arousal</measure>
    <time_frame>Screening, end of 6-week treatment, 6-month followup</time_frame>
    <description>Score on Penn State Worry Questionnaire, and Dysfunctional Beliefs and Attitudes about Sleep Scale.
Both measures have been found to be successful in measuring mediators and moderators of treatment response.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic Stress</measure>
    <time_frame>Screening, end of 6-week treatment, 6-month followup</time_frame>
    <description>We are using two of the most widely utilized psychometric indices of past, present and chronic stress exposure: 1) the Trauma History Questionnaire, and 2) the Life Stressor Checklist revised, a clinical interview for lifetime exposure to stressful life events.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Insomnia</condition>
  <arm_group>
    <arm_group_label>Cognitive Behavioral Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cognitive Behavioral Therapy is designed to identify incorrect ideas about sleep, challenge their validity, and replace them with correct information. This therapy tries to reduce worry, anxiety, and fear that one won't sleep by providing accurate information about sleep.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sleep Restriction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sleep Restriction therapy will limit the time participants spend in bed in order to make sure they are sleepy enough to fall asleep quickly.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combined Therapy Treatment for Insomnia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Combined Therapy involves combining Sleep Restriction and Cognitive Therapy so that the two therapies reinforce each other.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Sleep Restriction</intervention_name>
    <description>Sleep Restriction therapy will limit the time spent in bed in order to make sure participants are sleepy enough to fall asleep quickly.</description>
    <arm_group_label>Sleep Restriction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Therapy</intervention_name>
    <description>Cognitive Behavioral Therapy is designed to identify incorrect ideas about sleep, challenge their validity, and replace them with correct information. This therapy tries to reduce worry, anxiety, and fear that one won't sleep by providing accurate information about sleep.</description>
    <arm_group_label>Cognitive Behavioral Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Combined Therapy</intervention_name>
    <description>Sleep Restriction and Cognitive Therapy will be combined so that the two therapies reinforce each other.</description>
    <arm_group_label>Combined Therapy Treatment for Insomnia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males or females of any racial or ethnic group, aged 60 years old or older

          -  Independent living (not in nursing home, etc.)

          -  English-speaking

          -  Subjective complaint of insomnia associated with daytime impairment or distress

          -  DSM 5 (Diagnostic and Statistical Manual V) diagnosis of insomnia

          -  Score &gt;10 on the Insomnia Severity Indexa

          -  Must live within 40 miles of Stanford University

        Exclusion Criteria:

          -  Montreal Cognitive Assessment Scale &lt;20

          -  Apnea-hypopnea index &gt;10 or Periodic limb movement associated arousals &gt; 5 per hour

          -  Use of medication specifically prescribed for sleep and unwilling or unable to
             discontinue &gt; one week prior to baseline data collection.

          -  Acute or unstable chronic illness: including but not limited to insulin dependent
             diabetes (adult onset diabetes, controlled with oral medications or diet is
             acceptable); uncontrolled thyroid disease, kidney, prostate or bladder conditions
             causing excessively frequent urination (&gt; 3 times per night); medically unstable
             congestive heart failure, angina, other severe cardiac illness as defined by treatment
             regimen changes in the prior 3 months; stroke with serious sequelae; cancer if &lt; 1
             year since end of treatment; asthma, emphysema, or other severe respiratory diseases
             uncontrolled with medications; conditions associated with chronic pain such as
             fibromyalgia; and neurological disorders such as Alzheimer's disease, Parkinson's
             disease and unstable epilepsy as defined by treatment regimen changes in the prior 3
             months.

          -  Use of CNS (central nervous system) active medications that would significantly impact
             sleep or alertness is allowed as long as the dose, timing, and formulation are stable
             (&gt; 4 weeks).

          -  Excessive caffeine consumption (â‰¥ three cups per day), excessive alcohol consumption
             (&gt; 14 drinks per week or &gt; 4 drinks per occasion), or illicit substances (by
             self-report).

          -  Major psychiatric diagnosis on Axis I of DSM-IV as tested by the Mini International
             Neuropsychiatric Interview (Version 5.0).

          -  Lives more than 40 miles from Stanford University
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jerome A. Yesavage, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA/Stanford</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alison Buchanan</last_name>
    <phone>650-849-0584</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Leah Friedman, PhD</last_name>
    <phone>650-493-5000</phone>
    <phone_ext>65436</phone_ext>
  </overall_contact_backup>
  <location>
    <facility>
      <name>VA Palo Alto Health Care System</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alison Buchanan</last_name>
      <phone>650-849-0584</phone>
    </contact>
    <contact_backup>
      <last_name>Mary Dinh</last_name>
      <phone>650-849-0584</phone>
    </contact_backup>
    <investigator>
      <last_name>Leah Friedman, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Clete Kushida, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 4, 2014</study_first_submitted>
  <study_first_submitted_qc>April 15, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 17, 2014</study_first_posted>
  <last_update_submitted>December 5, 2016</last_update_submitted>
  <last_update_submitted_qc>December 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Jerome A Yesavage,</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Older adults</keyword>
  <keyword>insomnia</keyword>
  <keyword>CBT-I (cognitive behavioral therapy-insomnia)</keyword>
  <keyword>Behavioral Therapy</keyword>
  <keyword>SRT (sleep restriction therapy)</keyword>
  <keyword>Cognitive Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

